ω3 LCPUFAs for Healthy Growth & Development of Infants & Young Children in

Status Completed

Clinical Trial Summary

New approaches are needed to prevent growth failure in children from low- and middle-income countries (LMIC). To date, nutrition intervention studies have focused on micronutrient and energy content of complementary foods and have yielded only small to moderate effects on growth and development. There appears to be a missing link that mediates and reduces the expected beneficial effect. Child populations in LMIC show an asymptomatic environmental enteropathy that is characterized by a reduced size of the small intestinal villi, decreased gut integrity and a chronic inflammatory response in the gut. Results from studies in industrialized countries suggest that ω3 long-chain polyunsaturated fatty acids (ω3 LCPUFAs) improve immune response and gut integrity. These reported beneficial effects could result in even more important physiological implications for children from LMIC and will ultimately contribute to their healthy growth and development.

The hypothesis of the OME³Jim study is that an increased intake of ω3 LCPUFAs through complementary foods and human milk has an effect on infant growth and development in a context of high malnutrition rates and low ω3 LCPUFAs intake. This study will identify whether intake by either or both mother and infant is more effective.

The specific objectives of the OME³Jim study are:

1. To test the effect of supplementing infants with an ω3 LCPUFAs fortified food supplement on infant growth, morbidity, nutritional status and development;

2. To test the effect of supplementing lactating mothers with an ω3 LCPUFAs oil capsule on infant growth, nutritional status and development;

3. To test the combined effect (dose response) of supplementing ω3 LCPUFAs to lactating mothers and infant on infant growth, morbidity, nutritional status and development:

4. To test the effect of ω3 LCPUFAs supplementation on ω3 LCPUFA status in infants and human milk.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01817634
Study type	Interventional
Source	University Ghent
Contact
Status	Completed
Phase	N/A
Start date	November 2013
Completion date	September 2016

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT05543759` - Simplified Treatment Protocol for Acute Malnutrition in Venezuela
Recruiting	`NCT04488718` - ESj- Powder Complete T&A Study	N/A
Completed	`NCT02858011` - The Effect of a Cash Transfer Program and Preventive Nutrition Packages on Household Welfare and Child Nutritional Status in Mali	Phase 4
Recruiting	`NCT05473312` - Women Supporting Women to Improve Infant and Child Feeding Practices	N/A
Completed	`NCT04067284` - Homemade Yogurt Supplementation to Prevent Stunting	N/A
Completed	`NCT02988180` - Intervention on Development and Growth at Children in Poverty	N/A
Completed	`NCT03886467` - Strategies to Increase Milk Consumption by Young Nepali Children	N/A
Terminated	`NCT04133766` - Community-based Nutrition Program Effectiveness Evaluation in Afghanistan	N/A
Active, not recruiting	`NCT04257383` - The Sugira Muryango PLAY Collaborative	N/A
Recruiting	`NCT05889520` - The UFIM (Ultraprocessed Foods In Breast Milk) Project
Completed	`NCT02427945` - Leveraging an Existing Large-scale Safe Water Program to Deliver Nutrition Messages at a Low Marginal Cost	N/A
Recruiting	`NCT05181293` - Mobile Gaming App to Improve Child Nutrition in Nigeria	N/A
Completed	`NCT02071563` - Effectiveness and Cost-Effectiveness of Four Formulations of Food Supplements for the Prevention of Wasting and Stunting in Burkina Faso	N/A
Completed	`NCT01497236` - Effectiveness of Nutritional Supplementation in Preventing Malnutrition in Children With Infection in Karamoja, Uganda	N/A
Completed	`NCT02914002` - Psychoeducational Intervention Model to Improve Nutritional Status in Low Resource Settings	N/A
Completed	`NCT02257437` - Acceptability of a Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement for Children Under Two in Cambodia	N/A
Completed	`NCT02258802` - Pilot Psychoeducational Intervention Model to Improve Nutritional Status in Low Resource Settings	N/A
Completed	`NCT03751475` - Optimizing Acute Malnutrition Management in Children Aged 6 to 59 Months in Democratic Republic of Congo	N/A
Completed	`NCT01873196` - Food Aid Quality Review: Feasibility and Acceptability Study of Corn Soy Blend and Fortified Vegetable Oil in Malawi	N/A
Recruiting	`NCT05774314` - The Impact of Community Health Workers on Child Malnutrition in the Philippines	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

ω3 LCPUFAs for Healthy Growth and Development of Infants and Young Children in Southwest Ethiopia — OME³Jim

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms